Growth momentum OncoLens is experiencing rapid growth with recognition as an Inc 5000 fastest growing company and multiple funding rounds in 2024, plus new board and advisory appointments. The launch of OncoLens Analytics expands its analytics capabilities and real world evidence initiatives. Sales opportunities include engaging large cancer centers and research networks with bundled analytics and RWEs, leveraging board and advisory connections to open doors, and offering enterprise licenses for cross site adoption.

AI powered value An AI driven analytics platform leverages structured and unstructured data to improve patient outcomes and proactively identify candidates for clinical trials and biomarker testing. This provides a strong ROI proposition for hospitals pursuing precision oncology and improved center throughput. Sales angle includes targeting health systems with AI powered decision support, emphasizing interoperability with Epic and other data sources to minimize deployment risk.

Collaborative network The OncoLens Research Network collaborates with industry partners to deliver curated research and real world evidence to cancer centers. This enables co development opportunities and access to data assets that may help with payer and regulatory requirements. For sales, propose joint go to market with industry partners and offer access to RWEs and research cohorts as a differentiator.

Revenue strength Financial strength signals include a solid revenue base and multiple recent funding rounds, along with growth recognition. This indicates capacity to scale, invest in customer success, and expand deployments across health systems. Sales implications include offering a scalable pricing model with tiers for hospitals, health systems, and research affiliates, and pursuing expansion into national cancer programs.

Platform integration The tech stack includes Looker and Epic Systems with Hadoop, .NET and TypeScript, underscoring enterprise readiness and strong data interoperability. This supports seamless EHR integration and advanced analytics that drive patient ID, trial matching and leakage prevention. Sales angle emphasizes targeting centers with large Epic footprints and offering co selling with Epic partner programs, along with highlighting the robust patient ID and trial recruitment features as key differentiators.